Over the past 12 months, 3 insiders at Denali Therapeutics Inc. filed 5 open-market SEC Form 4 transactions on DNLI: 0 purchases worth $0 and 5 sales worth $956K. Insiders have been net sellers over this period. The most recent filing was on Jan 6, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 6, 26 | Alexander O. SchuthCOFO and Secretary | SELL | 17.2K | $16.50 | $284K |
| Jan 6, 26 | Ryan J. WattsPresident and CEO | SELL | 35.2K | $16.50 | $581K |
| Aug 13, 25 | Carole HoChief Medical Officer | SELL | 806 | $14.64 | $12K |
| Aug 12, 25 | Carole HoChief Medical Officer | SELL | 2.9K | $13.58 | $40K |
| Aug 12, 25 | Alexander O. SchuthCOFO and Secretary | SELL | 2.9K | $13.58 | $40K |
| Jul 9, 25 | Ryan J. WattsPresident and CEO | SELL | 495.3K | $15.00 | $7.4M |
| Jan 7, 25 | Steve E. KrognesDirector | SELL | 3.3K | $20.81 | $69K |
| Jan 7, 25 | Carole HoChief Medical Officer | SELL | 2.9K | $20.81 | $60K |
| Jan 7, 25 | Alexander O. SchuthCOFO and Secretary | SELL | 2.9K | $20.81 | $60K |
| Jan 7, 25 | Ryan J. WattsPresident and CEO | SELL | 7.7K | $20.81 | $159K |
| Jan 6, 25 | Carole HoChief Medical Officer | SELL | 12.3K | $20.22 | $248K |
| Jan 6, 25 | Alexander O. SchuthCOFO and Secretary | SELL | 12.3K | $20.22 | $248K |
| Jan 6, 25 | Ryan J. WattsPresident and CEO | SELL | 29.3K | $20.22 | $592K |
| Jan 2, 25 | Vicki L SatoDirector | SELL | 3.1K | $20.91 | $64K |
| Dec 31, 24 | Steve E. KrognesDirector | SELL | 30.0K | $20.25 | $608K |
| Nov 11, 24 | David P SchenkeinDirector | SELL | 32.3K | $32.87 | $1.1M |
| Nov 7, 24 | Vicki L SatoDirector | SELL | 1.0K | $30.00 | $31K |
| Nov 7, 24 | Alexander O. SchuthCOFO and Secretary | SELL | 12.3K | $31.29 | $366K |
| Nov 1, 24 | Vicki L SatoDirector | SELL | 3.1K | $27.07 | $83K |
| Oct 18, 24 | Ryan J. WattsPresident and CEO | SELL | 40.0K | $27.69 | $1.1M |
| Sep 30, 24 | Steve E. KrognesDirector | SELL | 30.0K | $29.03 | $871K |
| Sep 13, 24 | Vicki L SatoDirector | SELL | 1.0K | $30.00 | $31K |
| Sep 3, 24 | Vicki L SatoDirector | SELL | 3.0K | $25.37 | $74K |
| Aug 21, 24 | Carole HoChief Medical Officer | SELL | 14.1K | $24.96 | $344K |
| Aug 21, 24 | Alexander O. SchuthCOFO and Secretary | SELL | 2.5K | $24.78 | $63K |
| Aug 20, 24 | Carole HoChief Medical Officer | SELL | 2.5K | $23.79 | $58K |
| Aug 20, 24 | Steve E. KrognesDirector | SELL | 1.7K | $23.79 | $41K |
| Aug 20, 24 | Alexander O. SchuthCOFO and Secretary | SELL | 3.4K | $23.79 | $79K |
| Aug 20, 24 | Ryan J. WattsPresident and CEO | SELL | 2.3K | $23.79 | $54K |
| Aug 13, 24 | Carole HoChief Medical Officer | SELL | 2.3K | $22.89 | $53K |
| Aug 13, 24 | Alexander O. SchuthCOFO and Secretary | SELL | 2.3K | $22.89 | $52K |
| Jul 1, 24 | Vicki L SatoDirector | SELL | 3.0K | $22.86 | $66K |
| Jul 1, 24 | Steve E. KrognesDirector | SELL | 29.9K | $22.80 | $661K |
| Jun 13, 24 | Steve E. KrognesDirector | SELL | 688 | $21.79 | $15K |
| Jun 6, 24 | Jennifer E. CookDirector | SELL | 1.5K | $21.73 | $32K |
| May 15, 24 | Vicki L SatoDirector | SELL | 1.7K | $20.39 | $34K |
| Apr 15, 24 | Vicki L SatoDirector | SELL | 1.7K | $18.29 | $30K |
| Apr 1, 24 | Steve E. KrognesDirector | SELL | 92.5K | $20.50 | $1.9M |
| Mar 15, 24 | Vicki L SatoDirector | SELL | 1.7K | $20.10 | $33K |
| Feb 15, 24 | Vicki L SatoDirector | SELL | 1.7K | $18.37 | $31K |
| Feb 14, 24 | Carole HoChief Medical Officer | SELL | 1.4K | $17.79 | $25K |
| Feb 14, 24 | Alexander O. SchuthCOFO and Secretary | SELL | 20.1K | $17.66 | $355K |
| Feb 13, 24 | Carole HoChief Medical Officer | SELL | 2.8K | $17.29 | $48K |
| Feb 13, 24 | Steve E. KrognesDirector | SELL | 2.8K | $17.29 | $48K |
| Feb 13, 24 | Alexander O. SchuthCOFO and Secretary | SELL | 2.7K | $17.29 | $47K |
| Feb 13, 24 | Ryan J. WattsPresident and CEO | SELL | 9.6K | $17.29 | $166K |
| Jan 16, 24 | Vicki L SatoDirector | SELL | 1.7K | $18.42 | $31K |
| Jan 10, 24 | Carole HoChief Medical Officer | SELL | 4.7K | $19.02 | $89K |
| Jan 9, 24 | Ryan J. WattsPresident and CEO | SELL | 7.8K | $19.78 | $155K |
| Jan 5, 24 | Carole HoChief Medical Officer | SELL | 10.0K | $19.43 | $194K |
Over the past 12 months, insiders at Denali Therapeutics Inc. filed 0 open-market purchases worth $0 and 5 sales worth $956K on DNLI, which makes them net sellers over the period. The most recent Form 4 was filed on Jan 6, 26.
3 different insiders at Denali Therapeutics Inc. filed open-market SEC Form 4 transactions on DNLI over the last 12 months.
InsiderTape plots every DNLI insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Denali Therapeutics Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →